4Qureshi AR, Alveslrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemo- dialysis patients [J]. J Am Soe Nephrol, 2002, 13(1): 28-36.
5Fortes PC, de Moraes TP, Mendes JG, et al. Insulin resistance and glucose homeostasis in peritoneal dialysis [J]. Perit Dial Int, 2009, 29(2 Suppl): 145-148.
6Hurot JM, Cucherat M, Haugli M, et al. Effects of L-carnitine sup- plementation in maintenance hemodialysis patients: a systematic re- view [J]. J Am Soc Nephrol, 2002, 13(3): 708-714.
7Kalantar-Zadeh K, Rodriguez RA, fIumphreys MH. Association be- tween serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients [J]. Nephrol Dial Transplant, 2004,19(1): 141-149.
8Tabibi H, Hakcshzadeh F, Hedayati M, et al. Effects of 1-carnitine supplement on serum amyloid A and vascular inflammation markers in hcmodialysis patients: a randomized controllexi trial [J]. J Ren Nutr, 2011, 21(6)" 485-491.
9Shakeri A, Tabibi H, Hedayati M. Effects of L-carnitine supplementon serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp(a) hyperli- poproteinemia [J]. Hemodial Int, 2010, 14(4): 498-504.
